Your browser is no longer supported. Please, upgrade your browser.
Settings
SPPI Spectrum Pharmaceuticals, Inc. daily Stock Chart
SPPI [NASD]
Spectrum Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.00 Insider Own1.00% Shs Outstand102.90M Perf Week3.98%
Market Cap2.31B Forward P/E- EPS next Y-0.97 Insider Trans0.00% Shs Float90.40M Perf Month2.93%
Income-79.60M PEG- EPS next Q-0.25 Inst Own80.70% Short Float10.75% Perf Quarter13.47%
Sales135.00M P/S17.14 EPS this Y-20.20% Inst Trans9.30% Short Ratio8.99 Perf Half Y139.26%
Book/sh3.65 P/B6.16 EPS next Y6.70% ROA-18.40% Target Price29.25 Perf Year281.83%
Cash/sh2.41 P/C9.34 EPS next 5Y- ROE-33.30% 52W Range5.47 - 23.50 Perf YTD18.68%
Dividend- P/FCF- EPS past 5Y-25.30% ROI-17.80% 52W High-4.30% Beta1.59
Dividend %- Quick Ratio4.90 Sales past 5Y-5.40% Gross Margin65.00% 52W Low311.15% ATR1.19
Employees227 Current Ratio5.00 Sales Q/Q9.00% Oper. Margin-53.60% RSI (14)63.18 Volatility4.93% 5.84%
OptionableYes Debt/Eq0.33 EPS Q/Q-1.80% Profit Margin-58.90% Rel Volume1.40 Prev Close20.46
ShortableYes LT Debt/Eq0.33 EarningsMar 07 AMC Payout- Avg Volume1.08M Price22.49
Recom1.50 SMA206.61% SMA5013.59% SMA20067.54% Volume1,518,413 Change9.92%
Dec-18-17Initiated B. Riley FBR, Inc. Buy $26
Oct-24-17Initiated Guggenheim Buy $32
Oct-19-17Reiterated H.C. Wainwright Buy $20 → $29
Oct-04-17Reiterated H.C. Wainwright Buy $14 → $20
Aug-16-17Resumed H.C. Wainwright Buy $14
Feb-10-17Resumed Jefferies Buy
Nov-05-15Reiterated RBC Capital Mkts Outperform $13 → $12
Aug-07-15Reiterated RBC Capital Mkts Outperform $12 → $13
Apr-02-15Initiated FBR Capital Outperform $9
Feb-23-15Downgrade ROTH Capital Buy → Neutral $15 → $7
Jul-15-14Upgrade R. F. Lafferty Sell → Neutral $7.50
Oct-07-13Initiated HC Wainwright Buy $15
May-29-13Initiated Burrill Institutional Research Mkt Outperform $12
Mar-13-13Reiterated RBC Capital Mkts Outperform $19 → $16
Mar-13-13Downgrade WallachBeth Buy → Sell $20 → $5.50
May-02-11Reiterated MLV Capital Buy $12.50 → $20.50
Mar-25-11Initiated RBC Capital Mkts Outperform $12
Dec-07-10Reiterated Morgan Joseph Buy $8 → $10
Jan-12-10Upgrade Morgan Joseph Hold → Buy $8
Oct-14-09Reiterated Rodman & Renshaw Mkt Outperform $10 → $8
Feb-21-18 08:00AM  New Research Coverage Highlights Acacia Research, Zebra Technologies, VSE, Spectrum Pharmaceuticals, Agenus, and Williams Companies Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Feb-15-18 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2018 RBC Capital Markets Global Healthcare Conference on February 22nd Business Wire
Feb-12-18 08:28AM  [$$] Buying United, Selling Lilly, Rambus, Tronc Barrons.com
Feb-07-18 07:00AM  Wired News Spectrum Pharmas ROLONTIS Achieved Primary Endpoint in Phase-3 ADVANCE Study ACCESSWIRE
Feb-06-18 10:10AM  Spectrum Pharma's Rolontis Positive in Pivotal Cancer Study Zacks
08:38AM  Bristol-Myers Squibb, Spectrum Just Reported Key Late Stage Data Market Exclusive
Feb-05-18 09:33AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
07:00AM  Spectrum Pharmaceuticals Announces ROLONTIS (eflapegrastim) Met the Primary Endpoint in the Phase 3 ADVANCE Study Business Wire
Feb-02-18 05:06PM  Top 4 Small-Cap Stocks for 2018 Investopedia
Jan-23-18 08:10AM  Todays Research Reports on Trending Tickers: Spectrum Pharmaceuticals and ZIOPHARM Oncology ACCESSWIRE
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Noble Capital Markets' Fourteenth Annual Investor Conference Business Wire
Jan-22-18 05:40PM  Spectrum Pharmaceuticals Incs (NASDAQ:SPPI) Earnings Dropped -44.12%, Did Its Industry Show Weakness Too? Simply Wall St. +9.93%
Jan-19-18 10:06AM  Spectrum Pharmaceuticals Up 134% in 6 Months: Here's Why Zacks
Jan-08-18 06:03AM  The 10 Best Stocks of 2017 Motley Fool
Dec-21-17 06:25AM  Spectrum Pharmaceuticals Inc (NASDAQ:SPPI): What Does The Future Look Like? Simply Wall St.
Dec-18-17 09:37AM  Spectrum Pharma Dismisses CEO, Makes Leadership Changes Zacks
Dec-17-17 06:59PM  Spectrum Pharmaceuticals Announces Leadership Changes Business Wire
Dec-13-17 07:00AM  Spectrum Pharmaceuticals Highlights Two Oral Presentations on FOLOTYN® (pralatrexate injection) at the 59th Annual Meeting of the American Society of Hematology (ASH) Business Wire
Dec-12-17 10:32AM  Chart in Focus: Spectrum Pharmaceuticals Financials Market Realist
09:03AM  An Overview of Spectrum Pharmaceuticals Drug Pipeline Market Realist
07:33AM  Spectrum Pharmaceuticals Product Licensing Agreements Market Realist
Dec-11-17 05:10PM  A Look at Spectrum Pharmaceuticals Recent Acquisitions Market Realist
03:36PM  Analysts Recommendations for Spectrum Pharmaceuticals Market Realist
Dec-10-17 08:44PM  18 small-cap stocks that analysts expect to rise at least 50% in 2018 MarketWatch
Dec-04-17 07:00AM  Spectrum Pharmaceuticals Highlights 15 Abstracts at the 59th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia, December 9-12, 2017 Business Wire
Nov-27-17 10:06AM  Spectrum Doubles in 3 Months: What's Driving the Rally? Zacks
Nov-20-17 02:41PM  Edited Transcript of SPPI earnings conference call or presentation 2-Nov-17 8:30pm GMT Thomson Reuters StreetEvents
Nov-19-17 11:43AM  3 Biotech Stocks to Be Thankful for This Year Motley Fool
Nov-17-17 08:10AM  Todays Research Reports on Trending Tickers: Spectrum Pharmaceuticals and Myriad Genetics ACCESSWIRE -5.93%
Nov-13-17 07:50AM  Featured Company News - Infinity Shares Clinical and Translational Data from Monotherapy Dose-Escalation Component of Phase-1/1b Study for IPI-549 ACCESSWIRE
Nov-10-17 10:52AM  Ligand (LGND) Q3 Earnings & Revenues Top, 2017 View Raised Zacks
Nov-08-17 04:30PM  Stonegate Capital Partners Updates Coverage on Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ACCESSWIRE
11:00AM  Why Spectrum Pharmaceuticals Stock Soared in October Motley Fool
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2017 London Healthcare Conference on November 15th Business Wire
Nov-07-17 07:40AM  Recent Analysis Shows Philip Morris, Danaher, Skechers, Sally Beauty, Spectrum Pharma, and Textron Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-06-17 11:59AM  Top 4 Small-Cap Stocks for 2017 Investopedia
Nov-03-17 03:22PM  Spectrum (SPPI) Earnings, Sales Beat Q3 Estimates Zacks
09:24AM  Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers TheStreet.com
Nov-02-17 05:33PM  Spectrum Pharma reports 3Q loss Associated Press
04:02PM  Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update Business Wire
12:10PM  Spectrum Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Oct-31-17 04:39PM  Spectrum Pharmaceuticals (SPPI) Q3 Earnings: What's in Store? Zacks
Oct-30-17 07:00AM  Spectrum Pharmaceuticals Announces Initiation of a Multicenter Phase 2 Trial of Poziotinib in Non-Small Cell Lung Cancer (NSCLC) Patients with Exon 20 Insertion Mutation in EGFR or HER2 Business Wire
Oct-26-17 04:15PM  Harry Boxers three biotech-stock breakouts to watch MarketWatch
07:00AM  Spectrum Pharmaceuticals Announces Third Quarter 2017 Financial Results Teleconference and Webcast Business Wire
Oct-21-17 10:32AM  3 Healthcare Stocks That Soared This Week: Are They Buys? Motley Fool
Oct-19-17 08:10AM  Today's Research Reports on Stocks to Watch: Spectrum Pharmaceuticals and Protalix BioTherapeutics ACCESSWIRE -5.39%
Oct-18-17 05:04PM  What Happened in the Stock Market Today Motley Fool +36.03%
04:58PM  Why Spectrum Pharmaceuticals Stock Jumped Higher Today Motley Fool
12:52PM  Four Biotech And Health Care Breakouts Forbes
12:40PM  Investors Race to Buy Spectrum Pharmaceuticals, Inc. (SPPI) Shares; Heres Why SmarterAnalyst
09:29AM  Spectrum Shares Surge on Data for Lung Cancer Drug -- Biotech Movers TheStreet.com
08:50AM  Why Spectrum Pharmaceuticals Shares Are Surging 24/7 Wall St.
08:00AM  Today's Research Reports on Trending Tickers: Array BioPharma and Spectrum Pharmaceuticals ACCESSWIRE
Oct-17-17 10:15PM  Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung Cancer (NSCLC) Presented at the 18th IASLC World Conference on Lung Cancer in Japan Business Wire
Oct-10-17 04:30PM  Stonegate Capital Partners Updates Coverage on Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ACCESSWIRE
07:00AM  Spectrum Pharmaceuticals Announces Agreements to Exchange $69.5 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2018 for Common Stock and Cash Business Wire
Oct-09-17 12:02PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : October 9, 2017 Capital Cube
Sep-30-17 10:34AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Sep-29-17 10:38AM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : September 29, 2017 Capital Cube
08:00AM  Today's Research Reports on Trending Tickers: MannKind Corporation and Spectrum Pharmaceuticals ACCESSWIRE
07:00AM  Spectrum Pharmaceuticals Provides Update on At-The-Market Facility Business Wire
Sep-28-17 01:46PM  Here's Why Spectrum Pharmaceuticals, Inc. Is Surging Today Motley Fool +22.97%
07:00AM  Spectrum Pharmaceuticals Highlights Poziotinib Data in Lung Cancer to be Presented in an Oral Presentation at the 18th IASLC World Conference on Lung Cancer in Yokohama, Japan, October 15-18, 2017 Business Wire
Sep-05-17 07:00AM  Spectrum Pharmaceuticals to Present at Two Upcoming Investor Conferences in September Business Wire
Sep-01-17 10:38AM  Evomelas Market Share Is Increasing in 2017 Market Realist
Aug-25-17 05:34PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : August 25, 2017 Capital Cube
Aug-17-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 2017 Southern California Investor Conference in Newport Beach on Thursday, August 24th Business Wire
Aug-16-17 05:44PM  Spectrum (SPPI) Initiates Phase II Study for Cancer Drug Zacks
10:28AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-14-17 07:00AM  Spectrum Pharmaceuticals Announces Initiation of the Registrational Phase 3 Trial of Qapzola (apaziquone) in Patients with Non-Muscle Invasive Bladder Cancer (NMIBC) Business Wire
Aug-11-17 11:20PM  Edited Transcript of SPPI earnings conference call or presentation 3-Aug-17 8:30pm GMT Thomson Reuters StreetEvents +5.49%
Aug-08-17 11:14AM  Ligand (LGND) Q2 Earnings & Revenues Top, 2017 View Raised Zacks
Aug-07-17 08:20AM  Spectrum Pharmaceuticals (SPPI) Looks Good: Stock Jumps 22.2% Zacks
08:10AM  Today's Research Reports on Stocks to Watch: Cara Therapeutics, Inc. and Spectrum Pharmaceuticals ACCESSWIRE
Aug-04-17 02:10PM  Why Spectrum Pharmaceuticals Stock Is Bolting Higher Today Motley Fool +22.24%
10:07AM  Spectrum (SPPI) Q2 Loss Narrower than Expected, Sales Beat Zacks
Aug-03-17 04:02PM  Spectrum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Pipeline Update Business Wire
12:30PM  Investor Network: Spectrum Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-17 07:00AM  Spectrum Pharmaceuticals Announces Completion of Enrollment in the Phase 3 Pivotal Study (ADVANCE) of ROLONTIS (eflapegrastim), a Novel Long-Acting GCSF Business Wire
Jul-27-17 07:00AM  Spectrum Pharmaceuticals Announces Second Quarter 2017 Financial Results Teleconference and Webcast Business Wire -6.48%
Jun-19-17 07:00AM  Spectrum Pharmaceuticals Highlights Results of a Combination Study of FOLOTYN® (pralatrexate injection) Plus Romidepsin Presented at the 14th International Conference on Malignant Lymphoma (14-ICML) Meeting Business Wire
Jun-12-17 02:57PM  Spectrum Pharmaceuticals, Inc. Value Analysis (NASDAQ:SPPI) : June 12, 2017 Capital Cube
Jun-09-17 08:35AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SPPI-US : June 9, 2017 Capital Cube
Jun-02-17 07:00AM  Spectrum Pharmaceuticals Highlights Three Abstracts of Clinical Data at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, June 2-6, 2017 Business Wire
May-30-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2017 Global Healthcare Conference on June 6th Business Wire
May-19-17 03:11PM  Edited Transcript of SPPI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-16-17 07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2017 Health Care Conference on May 17 Business Wire
May-08-17 05:15PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : May 8, 2017 Capital Cube
May-05-17 10:29AM  Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017 Capital Cube
08:55AM  Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US : May 5, 2017 Capital Cube
May-04-17 01:36PM  Edited Transcript of SPPI earnings conference call or presentation 2-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-03-17 01:04PM  Why Spectrum Pharmaceuticals Stock Is Sinking Today Motley Fool -11.55%
10:09AM  Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma TheStreet.com
May-02-17 06:06PM  Spectrum Pharma reports 1Q loss Associated Press
04:02PM  Spectrum Pharmaceuticals Reports First Quarter 2017 Financial Results and Pipeline Update Business Wire
Apr-27-17 04:17PM  ETFs with exposure to Spectrum Pharmaceuticals, Inc. : April 27, 2017 Capital Cube
07:00AM  Spectrum Pharmaceuticals to Present Corporate Update at the 42nd Annual Deutsche Bank Health Care Conference on May 4 Business Wire
Apr-25-17 07:00AM  Spectrum Pharmaceuticals Announces First Quarter 2017 Financial Results Teleconference and Webcast Business Wire
Apr-21-17 07:30AM  Today's Research Reports on Biotech Stocks to Watch: Celldex Therapeutics and Spectrum Pharmaceuticals Accesswire
Spectrum Pharmaceuticals, Inc. develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor to treat patients with relapsed or refractory PTCL; ZEVALIN injection for patients with follicular non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for patients with relapsed or refractory PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients. It is also developing ROLONTIS for chemotherapy-induced neutropenia; QAPZOLA for intravesical instillation in post-transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer; and POZIOTINIB for treating breast and lung cancer. The company sells its drugs through a direct sales force in the United States; and through distributors in Europe. Spectrum Pharmaceuticals, Inc. has licensing and development agreement with Cell Therapeutics, Inc.; license agreement with Merck & Cie AG, Sloan-Kettering Institute, and Cydex Pharmaceuticals, Inc.; development and commercialization collaboration agreement with Allergan, Inc.; collaboration agreement with Nippon Kayaku Co., LTD.; licensing and collaboration agreement with Onxeo DK; and co-development and commercialization agreement with Hanmi Pharmaceutical Company. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was founded in 1987 and is headquartered in Henderson, Nevada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHROTRIYA RAJESH C MDDirectorJan 09Option Exercise7.605,199,58439,510,7846,988,631Jan 11 09:27 PM
SHROTRIYA RAJESH C MDChairman & CEONov 30Option Exercise3.15100,000315,000214,684Dec 04 07:42 PM
MAIDA ANTHONY E IIIDirectorJul 17Option Exercise6.9015,000103,50037,175Jul 18 06:02 PM
Krassner Stuart MitchellDirectorJul 17Option Exercise6.9015,000103,50067,444Jul 18 06:00 PM